XML 33 R18.htm IDEA: XBRL DOCUMENT v3.25.2
INCOME TAXES
 12 Months Ended
Aug. 02, 2025
Income Tax Disclosure [Abstract]  
INCOME TAXES
11.INCOME TAXES
The components of loss from continuing operations before income taxes were as follows:
For the Fiscal Year Ended
(in thousands)August 2, 2025August 3, 2024July 29, 2023
Loss from continuing operations before income taxes:
United States$(28,023)$(120,546)$(149,465)
Total loss from continuing operations before income taxes$(28,023)$(120,546)$(149,465)
The components of the income tax provision (benefit) were as follows:
For the Fiscal Year Ended
(in thousands)August 2, 2025August 3, 2024July 29, 2023
Current:
Federal$305 $(1,663)$951 
State516 2 (80)
Total current$821 $(1,661)$871 
Deferred:
Total deferred$— $— $— 
Total income tax provision (benefit)$821 $(1,661)$871 
The reconciliation of our effective tax rate to the statutory federal rate was as follows:
For the Fiscal Year Ended
(in thousands, except percentages)August 2, 2025August 3, 2024July 29, 2023
Taxes at federal statutory rate$(5,885)21.0 %$(25,315)21.0 %$(31,388)21.0 %
State taxes, net of federal effect456 (1.6)%(11)0.0 %(214)0.1 %
Stock-based compensation1,310 (4.7)%8,376 (6.9)%14,917 (10.0)%
Change in valuation allowance4,579 (16.3)%22,179 (18.4)%25,022 (16.7)%
R&D credits(975)3.5 %(6,032)5.0 %(8,426)5.6 %
Uncertain tax positions— — %(1,545)1.3 %31 0.0 %
Return to provision(52)0.2 %(207)0.2 %2 0.0 %
Excess officer’s compensation (2)
1,032 (3.7)%376 (0.3)%445 (0.3)%
Meals and entertainment (2)
321 (1.1)%380 (0.3)%415 (0.3)%
Other35 (0.1)%138 (0.1)%67 0.0 %
Effective tax rate (1)
$821 (2.9)%$(1,661)1.4 %$871 (0.6)%
(1) Due to rounding, percentages in this table may not sum to totals.
(2) Fiscal 2024 and fiscal 2023 amounts have been reclassified to conform to the current fiscal year presentation. Amounts were previously classified as “Other.”

Our provision for income taxes increased in fiscal 2025 as compared to fiscal 2024, primarily due to a decrease in pre-tax losses, partially offset by a decrease in the reversal of stock-based compensation expenses.
Our provision for income taxes decreased in fiscal 2024 as compared to fiscal 2023, primarily due to reserve releases from lapses in statutes of limitation and effective settlement of prior year tax positions.
The components of net deferred tax assets were as follows:
(in thousands)August 2, 2025August 3, 2024
Deferred tax assets:
Inventory reserve and UNICAP$14,612 $11,816 
Accruals and reserves2,165 1,937 
Research and development credits48,304 48,424 
Capitalized research and development costs48,602 40,094 
Stock-based compensation6,724 7,892 
Deferred revenue1,148 1,661 
Operating lease liability24,473 30,889 
Net operating losses53,880 59,938 
Other1,719 2,071 
Gross deferred tax assets$201,627 $204,722 
Less: valuation allowance(179,564)(176,732)
Deferred tax assets, net of valuation allowance$22,063 $27,990 
Deferred tax liabilities:
Depreciation and amortization$(8,281)$(10,747)
Operating lease right-of-use assets(13,400)(16,767)
Other(382)(476)
Gross deferred tax liabilities$(22,063)$(27,990)
Net deferred tax assets, net of valuation allowance$— $— 
As of August 2, 2025, and August 3, 2024, we had federal net operating loss carryforwards of $161.1 million and $186.7 million, respectively, which will be carried forward indefinitely. As of August 2, 2025, and August 3, 2024, we had federal research and development tax credit carryforwards of $57.3 million and $57.1 million, respectively. The research and development tax credits will expire beginning in 2038, if not utilized.
As of August 2, 2025, and August 3, 2024, we had state net operating loss carryforwards of $311.7 million and $328.5 million, respectively. Of these carryforwards, approximately $237.6 million will expire, if not utilized, in various years through 2045. The remaining carryforwards have no expiration. As of August 2, 2025, and August 3, 2024, we had California research and development tax credit carryforwards of $24.2 million and $24.1 million, respectively, which are not subject to expiration. Utilization of the net operating loss carryforwards, tax credits, and other tax attributes may be subject to various limitations due to the ownership change limitations provided by IRC Section 382 and similar state provisions. The annual limitation may result in the expiration of net operating losses and credits before their utilization and reduce our ability to offset future income with our tax attributes.
On July 4, 2025, the One Big Beautiful Bill Act (the “2025 Tax Act”) was signed into law. The 2025 Tax Act includes a broad range of tax reform that may affect the Company’s financial results, including domestic research cost expensing and 100% first-year bonus depreciation. For tax years beginning after December 31, 2024, taxpayers may elect to either (i) immediately deduct eligible Section 174 research expenditures or (ii) capitalize and amortize such costs over a period of no less than 60 months. We are currently evaluating the impact of the 2025 Tax Act upon our future effective tax rate, tax liabilities, and cash taxes.
UNCERTAIN TAX POSITIONS
A reconciliation of our unrecognized tax benefits is as follows:
(in thousands)August 2, 2025August 3, 2024July 29, 2023
Balance at the beginning of the year$32,816 $29,916 $26,106 
Lapse of statute of limitations— (377)(474)
Increase related to prior period tax positions33 2,572 1,134 
Decrease related to prior period tax positions(18)(1,927)— 
Increase related to current year tax positions341 2,632 3,150 
Balance at the end of the year
$33,172 $32,816 $29,916 
The amount of unrecognized tax benefits relating to our tax positions is subject to change based on future events including, but not limited to, the settlements of ongoing audits and/or the expiration of applicable statutes of limitations. The Company does not expect its gross unrecognized tax benefits to change significantly within the next 12 months. As of August 2, 2025, the total amount of unrecognized tax benefits, if recognized, would not affect the Company’s effective tax rate due to the existence of carryforwards and the valuation allowance in the United States and applicable U.S. state jurisdictions.
We recognize interest related to uncertain tax positions in our provision for income taxes. As of August 2, 2025, no interest or penalties have been recorded.
We file income tax returns in the U.S. federal and various state and local jurisdictions. As of August 2, 2025, our fiscal 2021 through fiscal 2024 tax returns are subject to potential examination in one or more jurisdictions.
We regularly assess whether it is more likely than not that we will realize our deferred tax assets in each taxing jurisdiction in which we operate. We consider many factors when assessing the likelihood of future realization, including our recent cumulative loss, earnings expectations in earlier future years, and other relevant factors. We continue to record a full valuation allowance on our U.S. federal and state net deferred tax assets due to cumulative historical losses. The valuation allowance primarily relates to federal and state deferred tax assets, including unrealized credit carryforwards and net operating losses. The valuation allowance increased by $2.8 million in fiscal 2025, and by $22.0 million in fiscal 2024.
A reconciliation of our valuation allowance was as follows:
(in thousands)August 2, 2025August 3, 2024
Valuation allowance at the beginning of the year$176,732 $154,757 
Valuation allowance charged to expense5,632 29,246 
Valuation allowance credited to other accounts(2,800)(7,271)
Valuation allowance at the end of the year$179,564 $176,732